| 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2024-080 | | --- | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | | 深圳新宙邦科技股份有限公司 关于回购股份进展情况的公告 一、回购股份进展的具体情况 深圳新宙邦科技股份有限公司（以下简称"公司"）于 2024 年 4 月 24 日召 开第六届董事会第十一次会议、第六届监事会第十一次会议，于 2024 年 5 月 14 日召开 2024 年第一次临时股东大会，审议通过了《关于回购公司股份方案的议 案》，同意公司使用自有资金以集中竞价交易方式回购公司已发行的部分人民币 普通股（A 股）股份（以下简称"本次回购"），本次回购股份将予以注销并相应 减少公司注册资本。本次回购资金总额不低于人民币 10,000 万元（含本数）且不 超过人民币 20,000 万元（含本数），具体回购资金金额以回购实施完成时实际回 购的金额为准。本次回购价格不超过人民币 45 元/股（含本数）。具体内容详见 公司于 2024 年 4 月 26 日在巨潮资讯网上披露的《关于回购公司股份方案的公 告》（公告编号：2024-02 ...

证券研究报告：电力设备 | 公司点评报告 2024 年 10 月 31 日 公司基本情况 总股本/流通股本（亿股）7.54 / 5.46 总市值/流通市值（亿元）291 / 211 52 周内最高/最低价 48.54 / 27.48 资产负债率(%) 45.3% 市盈率 28.34 第一大股东 覃九三 股票投资评级 新宙邦(300037) 个股表现 买入|维持 -37% -32% -27% -22% -17% -12% -7% -2% 3% 8% 2023-10 2024-01 2024-03 2024-06 2024-08 2024-10 新宙邦 电力设备 资料来源：聚源，中邮证券研究所 最新收盘价（元） 38.54 研究所 分析师:侯若雪 SAC 登记编号:S1340524100002 Email:houruoxue@cnpsec.com 分析师:虞洁攀 SAC 登记编号:S1340523050002 Email:yujiepan@cnpsec.com 电解液海外订单丰富，含氟化学品出货稳步增长 ⚫ 事件 2024 年 10 月 28 日，公司发布 2024 年三季度报告，2024 年 1-9 月公司实现 ...

研究报告 Research Report 30 Oct 2024 新宙邦 Shenzhen Capchem Technology (300037 CH) 2024Q3 扣非后净利润同比增长 3.61%，海德福产能逐步提升 Recurring Net Profit up 3.61% YOY in 2024Q3, Hydrafone Project is Gradual Increase in Production Capacity [Table_yemei1] 观点聚焦 Investment Focus | --- | --- | --- | --- | --- | |-------------------------------------------------------------|---------------------|--------------------|--------------------------------|-------------------| | [Table_Info] 维持优于大市 \n评级 | | | Maintain OUTPERFORM \n优于大市 | OUTP ...

Financial Performance - In Q3 2024, the company achieved a revenue of 2.085 billion CNY, a year-on-year decrease of 3.02% and a quarter-on-quarter increase of 0.85% [1] - The net profit attributable to the parent company, excluding non-recurring items, was 275 million CNY, representing a year-on-year increase of 3.61% and a quarter-on-quarter increase of 11.38% [1] - For the first three quarters of 2024, total revenue reached 5.667 billion CNY, a year-on-year increase of 1.51%, while the net profit attributable to the parent company was 706 million CNY, down 5.16% year-on-year [1] Market Dynamics - The company faced intense competition in the battery chemical products sector, leading to a continuous decline in product prices [1] - Despite increased shipment volumes, the overall gross margin was affected by intensified domestic market competition and declining sales prices [1] - The company is actively responding to changes in supply and demand by stabilizing market share, strengthening strategic customer collaborations, and expanding international markets [1] Product Development and Outlook - The organic fluorine chemical products and capacitor chemical products are expected to maintain stable growth due to leading technology [2] - The company is optimistic about the future of its fluorinated liquid products, which are widely applicable in various industries, including semiconductors and new energy vehicles [2] - The company has secured stable orders from existing customers and anticipates further growth as new production lines come online [3] International Expansion - The company began delivering lithium-ion battery electrolyte products to U.S. customers from its Poland factory in the second half of 2024, with stable customer orders [3] - The Poland factory has a production capacity of 40,000 tons per year, effectively meeting the demands of both European and U.S. markets [3] - The company has signed long-term supply agreements with numerous well-known overseas battery customers, with disclosed overseas order amounts reaching approximately 3.2 billion USD [3] Challenges and Strategic Responses - The overseas new energy vehicle market faces challenges such as local market development barriers and regulatory hurdles [4] - The company believes in the significant growth potential of the overseas market but acknowledges the need for time and strategic investment to ensure long-term competitiveness [4] - Management expenses decreased in Q3 2024 primarily due to performance-related expense accruals, while the overall gross margin slightly declined due to lower margins on high-volume electrolyte products [4]

证券研究报告 | 季报点评 gszqdatemark 2024 10 29 年 月 日 新宙邦（300037.SZ） 三季度业绩环比稳增，有机氟板块持续成长 事件：公司发布 2024 年三季报，三季度业绩环比大幅提升。 前三季度：实现营业收入 56.7 亿元，同比+1.5%；归母净利润 7.0 亿元，同比-12%；扣非净利润 7.1 亿元，同比-5.2%； Q3 单季度：实现营业收入 20.8 亿元，同比-3.0%，环比+0.9%；归 母净利润 2.86 亿元，同比+1.9%，环比+13.9%；扣非净利润 2.75 亿元，同比+3.6%，环比+11.4%； 盈利能力：Q3 单季度毛利率 25.7%，同比-2.5pct，环比-2.6pct；四 项费用率 9.3%，同比-1.8pct，环比-4.1pct；净利率 13.8%，同比 +0.6pct，环比+1.5pct。 氟化工产品持续放量，看好二三代产品成长性。海斯福一代医药中间体需 求稳定，二代产品氟化液已有数千吨稳定产能，稳居行业前列，现已供应 全球主流半导体制造商；全氟异丁腈千吨级产线亦为国内首条，未来二三 代产品在海外龙头产能退出的背景下有望逐步放量。此外， ...

[Table_StockNameRptType] 新宙邦（300037） 公司点评 | --- | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - Q3 performance met expectations with total revenue of 5.67 billion yuan, a year-on-year increase of 1.5%, and a net profit of 700 million yuan, a year-on-year decrease of 12.0% [2] - The company expects a significant increase in shipments in Q4, particularly in the U.S. market, which is anticipated to enhance profitability [3] - The fluorochemical segment showed a sequential profit increase in Q3, with expected contributions from capacitors and semiconductor chemicals also showing steady growth [3] - The company has effectively controlled expenses, with a decrease in the expense ratio and a slight increase in inventory [4] - The profit forecast for 2024-2026 is set at 10.65 billion, 14.42 billion, and 20.12 billion yuan respectively, with corresponding P/E ratios of 29, 21, and 15 [4] Summary by Sections Financial Performance - For Q3, the company reported revenue of 2.08 billion yuan, with a year-on-year decrease of 3.0% and a quarter-on-quarter increase of 0.8%. The net profit for Q3 was 290 million yuan, reflecting a quarter-on-quarter increase of 1.9% and a year-on-year increase of 13.9% [2] - The gross margin for Q3 was 25.7%, down 2.5 percentage points quarter-on-quarter, while the net profit margin was 13.7%, up 0.7 percentage points quarter-on-quarter [2] Shipment and Market Outlook - The company expects to ship approximately 135,000 tons of electrolyte in the first three quarters of 2024, a year-on-year increase of over 40%, with Q3 shipments reaching over 56,000 tons, a year-on-year increase of over 30% [3] - The company anticipates that shipments will stabilize in Q4, with total shipments for the year projected to be between 190,000 and 200,000 tons, representing a year-on-year increase of about 50% [3] Profitability and Expense Management - The fluorochemical segment is expected to contribute over 200 million yuan in profit for Q3, with a sequential increase of 7% [3] - The company reported a decrease in total expenses to 690 million yuan for the first three quarters of 2024, down 4.8% year-on-year, with a significant reduction in Q3 expenses [4] Valuation and Price Target - The target price for the company is set at 57 yuan, based on a projected P/E ratio of 30x for 2025, reflecting strong competitive advantages in the fluorochemical sector and a recovery in electrolyte pricing [4]

| 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2024-078 | | --- | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | | 深圳新宙邦科技股份有限公司 关于变更公司经营范围并修订《公司章程》的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 深圳新宙邦科技股份有限公司（以下简称"公司"）于2024年10月25日召开 第六届董事会第十五次会议、第六届监事会第十四次会议，审议通过了《关于变 更公司经营范围并修订<公司章程>的议案》，现将有关事项公告如下： 一、公司经营范围变更情况 根据公司经营发展需要，公司拟对经营范围进行增项，具体变更情况如下： | 变更前 | 变更后 | | --- | --- | | 经依法登记，公司的经营范围：铝电解 | 经依法登记，公司的经营范围：铝电解 | | 电容器、锂离子二级电池专用电子化 | 电容器、锂离子二级电池专用电子化 | | 学材料的开发和产销（以上不含限制 | 学材料的开发和产销（以上不含限制 | | 项目）；经营进出口业务（按深贸管登 | 项目）；经营进 ...

深圳新宙邦科技股份有限公司 2024 年第三季度报告 | --- | --- | --- | --- | |---------------------------------------|---------------------------------------|------------------------------------------------------------------------------------------------|---------------------| | | | | | | 证券代码： 300037 债券代码： 123158 | 证券简称：新宙邦 债券简称：宙邦转债 | | 公告编号： 2024-077 | | | 深圳新宙邦科技股份有限公司 | | | | | 2024 年第三季度报告 | | | | | | 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 | | 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大 遗漏，并承担个别和连 ...

| 证券代码：300037 | 证券简称：新宙邦 | 公告编号：2024-074 | | --- | --- | --- | | 债券代码：123158 | 债券简称：宙邦转债 | | 深圳新宙邦科技股份有限公司 第六届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 公司第六届董事会审计委员会审议通过了该议案中的财务报告部分。 表决结果：9 票同意，0 票反对，0 票弃权，获得通过。 二、审议通过了《关于<公司 2024 年第三季度安全生产专题报告>的议案》 董事会审议了公司 EHS 中心提交的《公司 2024 年第三季度安全生产专题报 告》，讨论并同意公司 2024 年第三季度安全生产工作总结及 2024 年第四季度 EHS 重点工作和目标，全面落实企业安全生产主体责任有关事项。 表决结果：9 票同意，0 票反对，0 票弃权，获得通过。 1 三、审议通过了《关于修订<董事、监事和高级管理人员所持本公司股份及 其变动管理制度>的议案》 深圳新宙邦科技股份有限公司（以下简称"公司"）第六届董事会第十五次 会议于2024年10月25日以 ...